Endomorphin-1 analogues containing beta-proline are mu-opioid receptor agonists and display enhanced enzymatic hydrolysis resistance

J Med Chem. 2002 Jun 6;45(12):2571-8. doi: 10.1021/jm011059z.

Abstract

In this paper we describe the synthesis and affinity toward the mu-opioid receptor of some tetrapeptides obtained from endomorphin-1, H-Tyr-Pro-Trp-Phe-NH(2) (1), by substituting each amino acid in turn with its homologue. The ability to bind mu-opioid receptors depends on the beta-amino acid, and in particular 4, which contains beta-L-Pro, has a K(I) in the nanomolar range. The peptides 4 and 5 are significantly more resistant to enzymatic hydrolysis than 1. The same compounds, as well as the mu-opioid receptor agonist DAMGO, produced a concentration-dependent inhibition of forskolin-stimulated cyclic AMP formation, thus behaving as mu-opioid agonists. These features suggest that this novel class of endomorphin-1 analogues may represent suitable candidates for the in vivo investigation as potential mu-opioid receptor agonists.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Binding, Competitive
  • Brain / metabolism
  • CD13 Antigens / chemistry
  • Carboxypeptidases / chemistry
  • Cathepsin A
  • Chymotrypsin / chemistry
  • Cyclic AMP / biosynthesis
  • Hydrolysis
  • In Vitro Techniques
  • Oligopeptides / chemical synthesis*
  • Oligopeptides / chemistry
  • Oligopeptides / pharmacology
  • Proline / analogs & derivatives*
  • Proline / chemistry*
  • Radioligand Assay
  • Rats
  • Receptors, Opioid, mu / agonists*
  • Receptors, Opioid, mu / metabolism
  • Stereoisomerism
  • Tumor Cells, Cultured

Substances

  • Oligopeptides
  • Receptors, Opioid, mu
  • endomorphin 1
  • Proline
  • Cyclic AMP
  • Carboxypeptidases
  • CD13 Antigens
  • Cathepsin A
  • Chymotrypsin
  • alpha-chymotrypsin
  • beta-proline